Oxford Science Enterprises PLC

Oxford Science Enterprises PLC, based in the UK, specializes in funding and building innovative companies that address major global challenges in Deep Tech, Life Sciences, and Health Tech sectors. Founded in 2015 and headquartered in Oxford, UK, Oxford Science Enterprises PLC focuses on fostering startups that leverage cutting-edge research for market solutions. The company has executed 7 deals, with the most recent one occurring on March 12, 2025, when it raised GBP 15 million from Aviva Investors, marking a strategic investment target for growth in innovative sectors. CEO Ed Bussey, who has a history of founding technology-driven firms, leads the company.

Oxford Science Enterprises primarily focuses on identifying, funding, and supporting innovative companies addressing significant global challenges. In Deep Tech, it advances foundational technologies for the fourth industrial revolution. In Life Sciences, the company partners with top scientists to transform research into new therapies, improving patient outcomes. In Health Tech, OSE aids innovators in developing digital health solutions to facilitate technology adoption in healthcare.

Their global offerings cater to a varied clientele, including academic institutions and healthcare providers across North America, Europe, and Asia. In the most recent fiscal year of 2023, Oxford Science Enterprises reported revenue of GBP 8,054,480, with an EBITDA of GBP -178,738,551. 6, illustrating the financial complexities associated with startup investments and market positioning. In March 2025, Oxford Science Enterprises PLC raised GBP 15 million in venture funding from Aviva Investors.

This capital will be allocated to expand their financial service platform, aiming to enhance their product offerings. The company is actively looking to penetrate new markets, seeking opportunities for growth and collaboration that could potentially occur in the upcoming years.